A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease
Titel:
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease
Auteur:
Papaldo, P. Fabi, A. Ferretti, G. Mottolese, M. Cianciulli, A.M. Di Cocco, B. Pino, M.S. Carlini, P. Di Cosimo, S. Sacchi, I. Sperduti, I. Nardoni, C. Cognetti, F.